Ae. Girard et al., CORRELATION OF INCREASED AZITHROMYCIN CONCENTRATIONS WITH PHAGOCYTE INFILTRATION INTO SITES OF LOCALIZED INFECTION, Journal of antimicrobial chemotherapy, 37, 1996, pp. 9-19
Azithromycin reaches high concentrations in phagocytic and other host
cells, suggesting that they may transport this agent to specific sites
of infection. Models of localized infection (Haemophilus influenzae m
iddle ear infection in gerbils, Streptococcus pyogenes implanted conta
minated paper disc and Streptococcus pneumoniae pneumonia in mice) tha
t induced severe inflammatory response after challenge were used to ex
plore this hypothesis. Animals were given a single 100 or 50 mg/kg po
dose of azithromycin at various times from 2 to 120 h following introd
uction of a pathogen or sterile medium. When azithromycin was given du
ring a period of little or no inflammation, there was marginal differe
nce between concentrations found in infected or non-infected sites (bu
lla, disc, lung). However, when the compound was given during a period
of inflammation, considerably higher drug concentrations were found i
n infected sites than in non-infected sites at 5-24 h after dosing (0.
38-0.44 mg/c compared with 0.07-0.14 mg/L of bulla wash; 1.01-1.75 mu
g compared with less than or equal to 0.01-0.03 mu g at the disc site;
1.72-5.28 mg/kg compared with 0.7-1.53 mg/kg of lung). When the obser
vation periods were extended to include 48, 56 or 96 h after dosing, t
he ratio of azithromycin infection site concentration: serum concentra
tion steadily increased with time in all model systems (middle ear, im
planted disc and pneumonia), reflecting the maintenance of concentrati
ons at the sites of infection, while serum concentrations declined. Bi
oassay of cell pellets and supernatants, obtained from pooled bulla wa
shes of gerbils treated with azithromycin during a period of inflammat
ion, revealed that cellular components accounted for about 75% of the
azithromycin detected. These data show that increased azithromycin con
centrations occur at sites of localized infection. This correlates wit
h the presence of inflammation and is associated with the cellular com
ponents of the inflammatory response. Therefore, phagocytes may be imp
ortant vehicles for delivering azithromycin to and sustaining azithrom
ycin concentrations at sites of infection.